Home

Genomic Valley Biotech Ltd 52 Week High

Image

Genomic Valley Biotech Ltd

NSE: GENOMICVALLEY

YEARHIGH

₹ 108.15

Last updated on: Feb 21, 2025

Key Highlights

  • The 52 Week HIGH of Genomic Valley Biotech Ltd is ₹ 108.15 as of 21 Feb 25 .

Company Fundamentals for Genomic Valley Biotech Ltd

Market Price of Genomic Valley Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Genomic Valley Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 202560.97
20 Feb 202559.78
19 Feb 202558.61
18 Feb 202555.82
17 Feb 202553.17
14 Feb 202550.64
13 Feb 202548.23
12 Feb 202545.94
11 Feb 202543.76
10 Feb 202543.5

Asset Value vs Market Value of Genomic Valley Biotech Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Genomic Valley Biotech Ltd News Hub

Genomic Valley Biotech standalone net profit rises 650.00% in the September 2024 quarter

Net profit of Genomic Valley Biotech rose 650.00% to Rs 0.15 crore in the quarter ended September 20

Read more

08 Oct 24

Genomic Valley Biotech to discuss results

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 7 October 202

Read more

03 Oct 24

Genomic Valley Biotech to convene board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2

Read more

11 Feb 25

Genomic Valley Biotech schedules AGM

Genomic Valley Biotech announced that the Annual General Meeting(AGM) of the company will be held on

Read more

07 Dec 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Genomic Valley Biotech Ltd

What is the significance of Genomic Valley Biotech Ltd reaching its 52-week high?

Genomic Valley Biotech Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Genomic Valley Biotech Ltd 52-week high?

Investors monitor Genomic Valley Biotech Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Genomic Valley Biotech Ltd a good buy when it hits its 52-week high?

Whether Genomic Valley Biotech Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Genomic Valley Biotech Ltd fundamentals.

What should I consider before investing in Genomic Valley Biotech Ltd at its 52-week high?

Before investing in Genomic Valley Biotech Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Genomic Valley Biotech Ltd stock price continue to rise after reaching its 52-week high?

Genomic Valley Biotech Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions